NVEC · NVE Corporation

The thesis

NVE Corporation's recovery case failed its repeat test: fiscal second-quarter product sales of about $5.58 million, reported 21 October 2026, fell far short of the $10,734,735 booked in the quarter ended 30 June 2026. The shares closed at $68.36 on 22 October 2026, and the next quarterly report decides whether June was a one-off order or the start of a higher run rate.

NVE's 21 October 2026 release put total revenue at $5.835 million, down 8% from $6.347 million a year earlier. The narrative has weakened: the 22 July 2026 earnings jump that drove the shares to a $133.06 52-week high has not been repeated, and the shares closed 48.6% below that high. A daily close below $60 would extend the post-report decline.

Bullish and bearish views on NVE Corporation

The bull case on NVE Corporation (NVEC), in brief: Six-month revenue is still higher. The bear case: The quarter ended 30 June 2026 had product sales of $10,734,735.

Bull case

• Six-month revenue is still higher. NVE reported first-half fiscal 2027 revenue of $16.9 million, up 36%, and CEO Peter G. Eames cited the 36% increase in the 21 October 2026 release. The June quarter still sits inside that figure.
• Contract research revenue grew. Contract research and development revenue rose 25% to about $0.26 million in the quarter ended 30 September 2026, per the 21 October 2026 release.

• The dividend is intact. The board declared a $1.00 quarterly dividend payable 30 November 2026 to holders of record on 2 November 2026, the same amount as the prior year's second-quarter dividend.

Bear case

• The quarter ended 30 June 2026 had product sales of $10,734,735. That quarter now looks like an outlier rather than a new run rate.
• Earnings per share slipped. Benzinga reported diluted earnings per share of $0.65 against $0.68 and sales of $5.835 million against $6.347 million on 21 October 2026.
• The market sold the report hard. Benzinga reported on 21 October 2026 that the shares fell 21% after the bell. The adjusted close was $113.82 on 9 October 2026 and $68.36 on 22 October 2026.
• Customer concentration is a stated risk. NVE's release lists reliance on several large customers as a forward-looking risk. Lumpy orders from a few buyers fit the June-to-September swing in product sales.
• A director sold earlier in the rise. Chairman Daniel A. Baker reported open-market sales of 21,140 shares on 8 September 2026 at $101 and $101.54, per SEC Form 4 accession 0001167691-26-000011.
• A law firm announced an investigation. Glancy Prongay Wolke & Rotter LLP announced an investigation into NVE on 22 October 2026. The headline carries no detail, and no claim or filing has been confirmed.

Price setup

The adjusted close on 22 October 2026 was $68.36, 48.6% below the $133.06 52-week high. The shares have fallen 41.3% over three months, per adjusted daily closes. The 14-day relative strength index (RSI) was 17.8 on 22 October 2026, against 68.7 on 9 October 2026. A reading under 30 marks a sharp, fast decline.

The July spike took the shares to $132.07 on 23 July 2026, when Benzinga reported a 52.4% one-day gain. The shares then fell to $100.51 on 11 September 2026 and recovered to $113.82 by 9 October 2026. The $105 area that anchored the prior note has been lost, and the post-report close sits well below the September low.

Crowding evidence has mostly unwound. Heavy attention came on 23 July 2026 and again on 21 October 2026 and 22 October 2026 in Benzinga's mover lists and the law-firm announcement. The earnings date is now past, and no insider purchases are reported in the sources checked.

Catalysts, next 30 days

• 2 November 2026: dividend record date. Holders of record on this date receive the $1.00 quarterly dividend payable 30 November 2026.
• ~12 November to 14 November 2026 (est.): Form 10-Q. NVE's quarterly filing, if filed on its usual schedule, would add order, customer and backlog detail the press release omitted. The date is unconfirmed.
• Next insider filings. Any SEC Form 4 from a director or officer after the drop would show how insiders read the price. No date is scheduled.
• ~2027-01 (est.): fiscal third-quarter results. This report is outside the 30-day window but is the next test of whether product sales recover toward the June level.

What would change the view

The case breaks further if the shares close below $60 on a daily basis, or if product sales in the quarter ending 31 December 2026 stay at or below the roughly $5.58 million reported for September. A 10-Q showing concentrated or delayed customer orders would add to that.

The case improves if the next quarterly product sales return toward the $10,734,735 June level, or if filings show the June orders were part of a continuing backlog. Disclosure of what the law-firm investigation concerns could change the reading in either direction.

What it trades with

NVE is a small spintronics sensor and coupler maker with a thin share float and a market that reacted by more than 50% on a single quarter in July. Its moves have tracked its own reports more than broad indexes. On 22 October 2026 the Nasdaq fell about 400 points in Benzinga's market wrap, so some of that day's decline may reflect the wider market, though the post-report drop came first.